We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medica... read more Featured Products: More products

Download Mobile App




New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds

By LabMedica International staff writers
Posted on 25 Jun 2024
Print article
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)
Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)

HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) now deliver combined results for complete blood count (CBC)/differential (DIFF) and ESR from whole blood in just 60 seconds. This integration provides a more comprehensive assessment of inflammatory diseases, adding significant value to the instruments' existing extensive functionalities.

The integration of ESR into its three new analyzers has been made possible through HORIBA's innovative CoRA (Correlated Rouleaux Analysis) technology. By combining CBC and 5-population white blood cell DIFF with rapid ESR, calibrated to the Westergren reference method, these compact analyzers can reduce both costs per test and turnaround times, while also saving laboratory space. Additionally, both the Yumizen H550E and H500E models feature enhanced connectivity for data management through HORIBA’s Yumizen P8000 middleware and Yumicare, a remote technical support tool that ensures secure connections to the instruments for monitoring workload, reagent consumption, quality control, and instrument alarms.

The evolution of the Yumizen H550 range has also seen the inclusion of i-DoubleDiff technologies, which utilize artificial intelligence (AI) to provide score flags for infectious diseases such as malaria and dengue fever. This feature enhances the diagnostic speed and expands the utility of the analyzers in diverse medical environments, including both advanced and resource-limited settings. DoubleDiff technology further supports the addition of Normal leucocyte count (Lymphocyte, Monocyte, Neutrophil, Eosinophil, Basophil) + Abnormal leucocyte count (IMG, IMM, IML, LIC, ALY). With just two reagents, this technology has expanded the analytical capabilities of the analyzers from 27 to 37 parameters, offering deeper insights and more comprehensive results, especially in oncology. Thanks to its advanced technologies, affordability, reliability, and simplicity, the Yumizen H550 range is well-suited for a variety of clinical settings, including critical care, oncology, infectious disease management, blood banks, satellite laboratories, and health centers.

“Building on the global success of our previous Yumizen H550 range, we have designed the new analyzers to meet the increasing demand for affordable, robust, and highly capable hematology analyzers with connectivity that are suitable for any lab environment,” said Arnaud Pradel, President, HORIBA ABX SAS. “It is one instrument with endless possibilities, and the capabilities of our Yumizen H550 range continue to grow to meet even more clinical lab needs.”

Related Links:
HORIBA

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: The new DxC 500i Clinical Analyzer is an integrated clinical chemistry and immunoassay analyzer (Photo courtesy of Beckman Coulter Diagnostics)

Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability

As global healthcare systems increasingly shift towards networked laboratory operational models to enhance efficiency and patient access, there is a greater need for innovative solutions tailored to the... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: Color-enhanced scanning electron micrograph showing Salmonella Typhimurium (red) invading cultured human cells (Photo courtesy of Rocky Mountain Laboratories, NIAID, NIH)

AI Identifies Drug-Resistant Typhoid-Like Infection from Microscopy Images within Hours

Antimicrobial resistance is becoming a serious global health concern, making many infections increasingly difficult to treat and limiting available treatment options. This escalation in resistance raises... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.